Pediatric Heterozygous Hypercholesterolemia
1 clinical trials · Condition
◉ Watch Pediatric Heterozygous Hypercholesterolemia
| Record | Firm | Date |
|---|---|---|
| 8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial Hypercholesterolemia (NCT00739999) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2008-12-01 |
Track Pediatric Heterozygous Hypercholesterolemia automatically
Every clearance here is in the API, with alerts when new ones post.